CIK: 1601942 - Address: C/O Shattuck Labs, Inc., 500 W. 5Th Street, Suite 1200, Austin, TX 78701
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/8/24 06:05
10/7/24
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOP441.2103712,682D
6/26/24 16:15
6/26/24
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOP503.4701412,645D
6/5/24 06:05
6/4/24
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOM.d113.570302,631D
1/31/22 16:38
1/28/22
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOM.d184.670402,628D
11/12/21 06:10
11/10/21
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOM.d184.670402,624D
8/11/21 16:58
8/10/21
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOM.d184.670402,620D
5/25/21 18:59
5/21/21
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOS-26725.360-1102,616I
5/20/21 20:36
5/18/21
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOS.m-51525.550-20-12,627I
5/17/21 21:07
5/13/21
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOS.m-70726.130-27-12,647I
5/12/21 20:35
5/10/21
STTKShattuck Labs, Inc.DEHealthDrugPharmaceutical PreparationsSchreiber TaylorTXDOCEOS.m-1,02427.520-37-12,674I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact